Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Gilmara Pandolfo Zabot, Ornella Sari Cassol, Renata de Sá Brito Fróes, Genoile Oliveira Santana, Márcio Lubini, Daniela Oliveira Magro, Marcello Imbrizi, Antonio Carlos da Silva Moraes, Fabio Vieira Teixeira, Antonio José Tiburcio Alves Junior, Newton Luiz Tricarico Gasparetti Junior, Sandro da Costa Ferreira, Natália Sousa Freitas Queiroz, Paulo Gustavo Kotze, Omar Féres
BACKGROUND: Real-world data on the effectiveness and safety of ustekinumab (UST) in ulcerative colitis (UC) are lacking in Latin America. In this study, we aimed to describe the effectiveness and safety of UST in a real-world multicenter cohort of Brazilian patients with UC. METHODS: We conducted a multicenter retrospective observational cohort study, including patients with moderate-to-severe UC (total Mayo score 6-12, with an endoscopic subscore of 2 or 3) who received UST...
April 2024: Crohn's & colitis 360